Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients Up to Age Seventy-Five With Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.374
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Elsevier BV